Article
Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma
1 Jan 2011
Abstract excerpt
The prognosis for patients with large-cell neuroendocrine carcinoma (LCNEC) of the lung is extremely poor, and an optimal treatment has not yet been established. It has been recently reported that molecular-targeted therapies, such as tyrosine kinase inhibitors for epidermal growth factor receptor (EGFR), are effective in patients with lung carcinoma. In efforts to improve the prognosis of patients with LCNEC, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
